Pre-operative Radio-chemotherapy for Cervical Cancer
Author Information
Author(s): de la Rochefordiere Anne, Kirova Youlia, Alran Severine, Plancher Corine, Fourchotte Virginie, Beuzeboc Philippe, de Margerie Vincent, Petrow Peter, Sastre-Garau Xavier, Servois Vincent, Scholl Suzy, Cottu Paul, Mignot Laurent, de Cremoux Patricia, Salmon Remy
Primary Institution: Institut Curie, Paris, France
Hypothesis
The study aims to evaluate the treatment results of patients with FIGO stage IB2, IIA, IIB cervical carcinoma treated with pre-operative radio-chemotherapy followed by surgery.
Conclusion
The treatment of locally advanced cervical cancer requires a new multidisciplinary approach to improve survival and treatment tolerance.
Supporting Evidence
- 56% of patients achieved complete histological local-regional response.
- 80% of pelvic lymph nodes were free from microscopic disease.
- 54.1% of patients were alive and free of disease after a median follow-up of 40 months.
Takeaway
This study looked at how well a combination of radiation and chemotherapy works before surgery for women with advanced cervical cancer. It found that many patients responded well to the treatment.
Methodology
This was a retrospective study of 148 women treated with pre-operative radio-chemotherapy and surgery, with survival rates analyzed using Kaplan-Meier estimates.
Potential Biases
Potential biases may arise from the single-institution setting and retrospective design.
Limitations
The study is limited by its retrospective nature and the small sample size.
Participant Demographics
The median age of participants was 46 years, with 71% pre-menopausal and 97.1% of normal weight.
Statistical Information
P-Value
p = 0.03
Confidence Interval
[95% CI: 66–89]
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website